Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03144752 · ClinicalTrials.gov registry record
Optimizing Clinical Screening and Management of Maternal Mental Health: Predicting Women at Risk for Perinatal Depression
A clinical trial, sponsored by Janssen Research & Development.
- Completed
- Registry status
- 298
- Enrollment target
NCT03144752 is a clinical trial that has completed, run by Janssen Research & Development. The registered enrollment target is 298 participants.
The verdict
NCT03144752 has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- 298 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if medical, biological, psychological, and social risk factors can be used to develop algorithms that will predict perinatal depression (PND). Data capture will include baseline participant medical, psychological and family history, blood biomarkers, and psychosocial assessments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2017-04-14 |
| Est. Completion | 2019-05-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03144752
The ClinicalTrials.gov registry entry for NCT03144752 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 298 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03144752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03144752 about?
NCT03144752 is a clinical study titled "Optimizing Clinical Screening and Management of Maternal Mental Health: Predicting Women at Risk for Perinatal Depression". The purpose of this study is to determine if medical, biological, psychological, and social risk factors can be used to develop algorithms that will predict perinatal depression (PND). Data capture will include baseline participant medical, psychological and family history, blood biomarkers, and psy...
What is the current status of trial NCT03144752?
This trial is currently completed. The enrollment target is 298 participants. The study started on 2017-04-14. Estimated completion is 2019-05-05.
Who is sponsoring clinical trial NCT03144752?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.